Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2340-2351

  Cook, Andrew D ^a   Turner, Amanda L ^a   Braine, Emma L ^a   Pobjoy, Jarrad ^a   Lenzo, Jason C ^a   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL SUBPOPULATION; CHIMERA; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; LEUKOCYTE; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SYNOVIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE MARROW CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, KNOCKOUT; MYELOID CELLS;

EID: 79961114696     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30354     Document Type: Article

References (49)

1. Metcalf D,. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339: 27-30. (Pubitemid 19115887)
2. Hamilton JA, Stanley ER, Burgess AW, Shadduck RK,. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 1980; 103: 435-45. (Pubitemid 11104577)
3. Fleetwood AJ, Cook AD, Hamilton JA,. Functions of granulocyte-macrophage colony-stimulating factor. Crit Rev Immunol 2005; 25: 405-28. (Pubitemid 43068934)
4. Hamilton JA,. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-44. (Pubitemid 351913679)
5. Bagby GC Jr, Dinarello CA, Wallace P, Wagner C, Hefeneider S, McCall E,. Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest 1986; 78: 1316-23. (Pubitemid 17181571)
6. Zucali JR, Dinarello CA, Oblon DJ, Gross MA, Anderson L, Weiner RS,. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest 1986; 77: 1857-63. (Pubitemid 16062640)
7. Leizer T, Cebon J, Layton JE, Hamilton JA,. Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor. Blood 1990; 76: 1989-96.
8. Campbell IK, Novak U, Cebon J, Layton JE, Hamilton JA,. Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1. J Immunol 1991; 147: 1238-46.
9. Hamilton JA,. Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 1993; 342: 536-9. (Pubitemid 23259193)
10. Campbell IK, Rich MJ, Bischof RJ, Dunn AR, Grail D, Hamilton JA,. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 1998; 161: 3639-44.
11. Yang YH, Hamilton JA,. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum 2001; 44: 111-9. (Pubitemid 32113125)
12. Plater-Zyberk C, Joosten LA, Helsen MM, Hepp J, Baeuerle PA, van den Berg WB,. GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Ann Rheum Dis 2007; 66: 452-7. (Pubitemid 46580463)
13. McQualter JL, Darwiche R, Ewing C, Onuki M, Kay TW, Hamilton JA, et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med 2001; 194: 873-82.
14. Kitching AR, Ru Huang X, Turner AL, Tipping PG, Dunn AR, Holdsworth SR,. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J Am Soc Nephrol 2002; 13: 350-8. (Pubitemid 34106276)
15. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, Anderson GP,. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol 2004; 286: L877-85. (Pubitemid 38365075)
16. Bozinovski S, Jones JE, Vlahos R, Hamilton JA, Anderson GP,. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFÎB and AP-1 in vivo. J Biol Chem 2002; 277: 42808-14. (Pubitemid 35285656)
17. Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA,. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res 2001; 3: 293-8. (Pubitemid 32821522)
18. Vlahos R, Bozinovski S, Chan SP, Ivanov S, Linden A, Hamilton JA, et al. Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am J Respir Crit Care Med 2010; 182: 34-40.
19. Vlahos R, Bozinovski S, Hamilton JA, Anderson GP,. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther 2006; 112: 106-15. (Pubitemid 44301488)
20. Ponomarev ED, Shriver LP, Maresz K, Pedras-Vasconcelos J, Verthelyi D, Dittel BN,. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol 2007; 178: 39-48. (Pubitemid 46039660)
21. Timoshanko JR, Kitching AR, Semple TJ, Holdsworth SR, Tipping PG,. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. J Am Soc Nephrol 2005; 16: 2646-56.
22. Cook AD, Braine EL, Hamilton JA,. Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation. J Immunol 2004; 173: 4643-51. (Pubitemid 39280698)
23. Martinez FO, Sica A, Mantovani A, Locati M,. Macrophage activation and polarization. Front Biosci 2008; 13: 453-61. (Pubitemid 351599757)
24. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD,. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007; 178: 5245-52. (Pubitemid 46595309)
25. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004; 101: 4560-5. (Pubitemid 38437450)
26. Hamilton JA, Tak PP,. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases [review]. Arthritis Rheum 2009; 60: 1210-21.
27. Buchan GS, Palmer DG, Gibbins BL,. The response of human peripheral blood mononuclear phagocytes to rheumatoid arthritis. J Leukoc Biol 1985; 37: 221-30. (Pubitemid 15167355)
28. Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR,. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2: 189-202. (Pubitemid 32223726)
29. Stuhlmuller B, Ungethum U, Scholze S, Martinez L, Backhaus M, Kraetsch HG, et al. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 775-90.
30. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW,. Mononuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis? [review]. Arthritis Rheum 1997; 40: 5-18. (Pubitemid 27044031)
31. Wing EJ, Magee DM, Whiteside TL, Kaplan SS, Shadduck RK,. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor α and interferon in cancer patients. Blood 1989; 73: 643-6. (Pubitemid 19069162)
32. Geissmann F, Jung S, Littman DR,. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82. (Pubitemid 36859902)
33. Sunderkotter C, Nikolic T, Dillon MJ, van Rooijen N, Stehling M, Drevets DA, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172: 4410-7. (Pubitemid 38375256)
34. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 1994; 91: 5592-6. (Pubitemid 24174374)
35. Cook AD, De Nardo CM, Braine EL, Turner AL, Vlahos R, Way KJ, et al. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement. Arthritis Res Ther 2010; 12: R37.
36. Cook AD, Braine EL, Campbell IK, Hamilton JA,. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis. Am J Pathol 2002; 160: 917-26. (Pubitemid 34224581)
37. Campbell IK, Hamilton JA, Wicks IP,. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000; 30: 1568-75. (Pubitemid 30342798)
38. O'Garra A, Barbis D, Wu J, Hodgkin PD, Abrams J, Howard M,. The BCL1 B lymphoma responds to IL-4, IL-5, and GM-CSF. Cell Immunol 1989; 123: 189-200. (Pubitemid 19242691)
39. Lawlor KE, Campbell IK, O'Donnell K, Wu L, Wicks IP,. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis Rheum 2001; 44: 442-50.
40. + myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009; 113: 3190-7.
41. Chan J, Leenen PJ, Bertoncello I, Nishikawa SI, Hamilton JA,. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 1998; 92: 1423-31. (Pubitemid 28369057)
42. Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, Danoy P, et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001; 194: 321-30. (Pubitemid 32730806)
43. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-6.
44. Eyles JL, Hickey MJ, Norman MU, Croker BA, Roberts AW, Drake SF, et al. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 2008; 112: 5193-201.
45. Monach PA, Nigrovic PA, Chen M, Hock H, Lee DM, Benoist C, et al. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor Î, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum 2010; 62: 753-64.
46. Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006; 7: 284-92.
47. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K,. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-61.
48. Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN,. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor α antibody in rheumatoid arthritis. Arthritis Rheum 1996; 39: 1082-91. (Pubitemid 26240219)
49. Hamilton JA,. Colony stimulating factors, cytokines and monocyte-macrophages-some controversies. Immunol Today 1993; 14: 18-24. (Pubitemid 23028246)